Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

VERO Biotech Receives US FDA Approval of GENOSYL for the Delivery of Inhaled Nitric Oxide

firstwordpharmaDecember 22, 2019

Tag: VERO Biotech LLC , GENOSYL , Inhaled Nitric Oxide

PharmaSources Customer Service